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Optical Imaging of Radiolabeled Drugs in Tissue Sections Using the MicroImager 
 
Paul Dungel 
 
ABSTRACT 
 
The MicroImager is a fast, high resolution, real time, digital autoradiographic 
imaging tool with broad applications.  This study utilizes the MicroImager to evaluate 
radiolabeled drug behavior in subcutaneous tissue.  Experiments were conducted in 
conjunction with mathematical models to determine the diffusion coefficient (D) and 
elimination constant (k) for radiolabeled dexamethasone.   
Osmotic pumps containing [3H]dexamethasone were implanted into rat 
subcutaneous tissue over 6h, 24 h, and 60 h.  Local tissue was explanted and slides were 
prepared for imaging.  The MicroImager was then used to quantify the local 
concentration of 3H-dexamethasone in the tissue surrounding the tip of the osmotic pump.  
Betavision+ software was used to obtain local concentration profiles.  These were then 
compared to a mathematical model to determine the diffusion coefficient and elimination 
constant for the radiolabeled drug.  The diffusion coefficient for dexamethasone in rat 
subcutaneous tissue is 4.11 ± 1.77 x 10-10 m2/s.  The elimination constant is 3.65 ± 2.24 x 
10-5 s-1. 
A similar experiment was conducted to determine the diffusion coefficient 
through different means.  [3H]dexamethasone was injected into the rat subcutaneous 
 vii
tissue for a 2.5 min and a 20 min period.  A different mathematical model was applied 
and the diffusion coefficient was found to be 4.01 ± 2.01 x 10-10 m2/s. 
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Chapter One 
 
MicroImager 
Background of Radioimaging 
 The use of radioactive isotopes to investigate biological phenomenon is important 
for several reasons.  Radioactive tracers are incorporated into the substance being studied 
and rarely inhibit the molecules motion or binding characteristics. Also, degradation of 
the signal does not decrease over time when using an appropriate isotope.  This provides 
for long term storage and analysis without loss of data.  This valuable tool in 
contemporary medicine had its beginnings over 80 years ago.  Autoradiography was first 
applied to systemic biological investigation in 1924 by Lacassagne (1).  Using 
photographic emulsions, Lacassagne studied Polonium distribution in tissues.  
Photographic emulsions have been used to evaluate the presence and location of radiation 
in tissues ever since.   
 
Radiation 
 Elements (Hydrogen, Carbon, Iodine, etc) can exist naturally as unstable isotopes 
of stable atoms.  They can regain their stability by emitting energy in the form of 
radiation.  This radiation can have different forms and different energies.  Alpha, gamma, 
and beta radiation have different characteristics and are associated with specific decay 
activities (2). 
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 Alpha decay occurs when an alpha particle is emitted from the nucleus of an atom.  
An alpha particle is defined as 42 He.  Gamma radiation has no mass and is capable of the 
greatest penetrative distance.  This type of radiation is commonly used in X-ray imaging. 
 Beta radiation can have two forms.  A β- particle is an electron while a β+ particle 
is a positron.  Each of these has a mass 1/1840 that of a proton.  If a β- particle is emitted 
from the nucleus, the transformation that occurs is that a neutron changes to an electron 
and a proton.  On the other hand, if a β+ particle is emitted, a proton splits into a positron 
and a neutron.  The type of decay that occurs is dependant on the specific element (2).  
Tritium, the radiolabel used in my experiments, emits β- particles that are then detected 
and analyzed. 
 
Emulsion Film Autoradiography    
 The traditional method for visualizing radiation has been photographic emulsions.  
A photographic emulsion incorporates Silver Bromide (AgBr) crystals in a gelatin 
suspension.  Upon exposure of the emulsion to a radioactive sample, areas of the crystal 
that are irradiated undergo a transformation.  The free electron (β- particle) oxidized the 
silver and creates metallic silver at these locations.  After the “latent image” is processed, 
the results can be visualized.  This process can be time consuming and cumbersome (3). 
 
Phosphor Imaging 
Another modality has been developed that operates similarly to emulsion film 
autoradiography.  A sheet with a coating of excitable phosphor crystals is placed atop the 
sample.  Upon exposure, low energy electron-hole pairs are created by the interaction of 
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the phosphor with the incident radiation.  Most recombine and luminescence can be 
observed locally.  However, some of the new electrons become trapped and do not 
recombine.  Upon stimulation with a He-Ne (red) laser, these trapped electrons are freed 
and find available holes.  This creates a violet glow that is observed using fiberoptics.  
The signal from this system is then amplified by a photomultiplier and then digitized 
using a scanner (4).  Upon review, Kamarainen et al. (2006) found that compared to 
photostimulated luminescence, “…film autoradiography requires more time for 
optimizing, preparing, and analyzing films because of poor sensitivity and low 
linearity” (5). 
 
MicroImager Information 
Operating Principles 
 
 
 
Figure 1.  MicroImager with associated PC 
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 The recently developed MicroImager builds on previously developed imaging 
technology.  As the MicroImager is fully digital, no film or phosphor screen is necessary.  
The sample is placed on a slide and covered with a thin sheet of scintillating paper.  This 
paper converts beta particles to photons.  These photons are amplified in an Image 
Intensifier Tube and enter a CCD Camera.  The computer then assimilates the data into 
an observable image that is displayed to the user.  This system has several advantages 
over traditional imaging modalities.  Digital storage of data is more compact, easier to 
transport, and easier to view than photographic film or phosphor screens.  The high-
resolution (~20µm) and high speed of data acquisition (on the order of hours) is 
advantageous compared to previous technology.  Additionally, this system can be 
automated to process up to four samples in one run.  High throughput data analysis is 
valuable because it provides the investigator with time to focus on other tasks while 
acquiring important data. 
 The MicroImager also has the unprecedented ability to distinguish two different 
isotopes in one sample.  If isotopes emitting radiation at different energy levels are used 
(i.e. 3H and 14C), the software can differentiate between the two.  Each beta particle will 
have a different size “light spot” on the screen dependant on its energy.  After user 
standards are prepared, the software can determine the source of each “spot” and assign it 
to a specific isotope.  This can not be done using film emulsions or phosphor imaging. 
 5
Hardware Components of MicroImager 
Scintillating Sheet 
 
 
 A small, thin sheet of scintillating paper is placed over the sample in order to 
properly image the sample.  The MicroImager employs scintillating sheets made of 
SiY2O5 due to its desired properties (6).  The 10 micron thick sheet transforms beta decay 
from the sample into photons that then move through the image intensifier tube (IIT) on 
the way to the CCD camera.   
 
Image Intensifier Tube 
 After the photons are released from the scintillating sheet, they enter the image 
intensifier tube.  This double microchannel plate tube is an optoelectronic device that 
amplifies the intensity of the incoming light by a factor of 30000 (6).  The amplified 
image is then transferred to a phosphor screen that is lined with an 800 Angstrom 
aluminized layer.  This creates a polarizing current that is picked up by the CCD camera. 
Figure 2.  Scintillating sheet on slide 
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CCD Camera 
 The Charge Coupled Device (CCD) Camera incorporated into the MicroImager 
has a 576 x 384 pixel screen to integrate incident light.  The matrix structure of the CCD 
camera allows high speed, high resolution images to be acquired.  An optical spot is 
detected by the CCD and then analyzed by an imbedded chip to determine the spot’s 
center of gravity (7).  This enables the MicroImager to have a spatial resolution of 15-20 
µm.  The digital signal created is displayed on the PC screen and can then be processed 
using Betavision+ software.  
 
Software Components of MicroImager 
The images acquired with the MicroImager can then be processed using a 
dedicated software package called Beta Vision+.  This software has broad applications 
for data analysis and visual interpretation.  
Quantification of the data can be conducted in various ways.  The final image is a 
composite of acquisitions done at numerous time points.  One can view the entire set of 
data, or observe only a specific time segment of the acquisition.  For example, if the 
sample was run for 10 hours, one can observe the final image with 10 hours of decay 
events.  On the other hand, one can view the first or last 3 hours of acquisitions.  
Furthermore, one can observe the middle 5 hours of acquisition.  This feature can be 
valuable for several reasons.  First, if decay events should remain constant over time, this 
can be confirmed by comparing initial acquisition with final acquisition.  Secondly, if the 
radioactive tracer used has a short half-life, one can run the sample and observe the 
decrease in decay over time.  This method enables one to focus on data based on the time 
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it was obtained.  In addition to the temporal distribution, more important data analysis is 
conducted on the spatial distribution of the signal.   
There are several different tools available in Beta Vision+ to aid in spatial 
analysis of the image.  The image of the decay events is acquired using a monochrome 
camera, yielding a black and white image.  The intensity of different locations can be 
difficult to observe in grayscale images, so pseudocolor can be applied using a preset 
look-up-table (LUT) or a custom LUT.  The range of this scale can be adjusted per user 
inputs. 
 
 
 
 
Additionally, there are many other processing and quantitative tools available in 
the Beta Vision+ software.  Among those that will be discussed are the Grid ROI, Circle 
ROI, Line Profile tool and other tracing tools. 
 
 
 
Figure 3.  The original autoradiogram of [3H]dexamethasone as acquired by the 
MicroImager (left) and the same image with a psuedocolor LUT applied (right).  
The image on the right more clearly shows the variation in intensity 
 8
Grid ROI 
The Grid Region of Interest (ROI) 
tool is useful to iteratively analyze a 
region of the image.  After clicking on the 
Grid ROI icon, the user can input the 
number of rows and columns desired in 
the rectangular region.  Then, using the 
mouse, one can draw a grid on the desired  
area of the image.  After this, the Result 
Viewer can be enabled to display information 
 about each grid square.  The data displayed includes the area of each grid and counts 
within each gridsquare. This data can be exported to other programs such as Excel or 
Matlab for further analysis.   
 
Circle ROI 
The Circle Region of Interest (ROI) 
tool can also be used to gather data in specific 
locations on the image.  Several Circle ROI’s 
can be made to radiate from a central point.  
This is convenient when investigating the 
radial symmetry of the radioactive tracer.  The 
data attained from individual Circle ROI’s 
can be exported to Excel and processed further. 
Figure 4.  Grid overlay on 
autoradiogram 
Figure 5.  Circle ROI overlay on 
autoradiogram 
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Line Profile 
Linear characterization of counts 
can be done using the Line Profile Tool.  
Upon clicking on the Line Profile tool 
icon, the user can draw a line of desired 
length along the image and obtain counts 
information along this line.  The Beta 
Vision + software measures the counts 
within a 1 mm width at 0.02 mm intervals 
 along the drawn line.  Alternatively, there is another tool available which will measure 
the counts along a line.  This PolyLine tool, however, allows the user to adjust the width 
of the area being analyzed.  These line profile tools are useful for investigating linear 
distribution of isotope in the sample.   
 
Tracing 
 Spatial correspondence to the actual sample is important in order to determine the 
validity of the data.  An optical image can be acquired either prior to, or after 
radioimaging.  This is done by shining an LED light on the sample to obtain an optical 
density image of the sample.  This image is spatially aligned with the autoradiogram 
because they are both acquired with the same camera without moving the stage or the 
slide.  With the standard package Betavision+ software, one can not directly overlay an 
optical image with an autoradiographic image.  However, using the tracing tools in the 
measurement toolbar, one can correlate the two images.  One can trace an ouline of the 
Figure 6.  Line Profile on 
autoradiogram 
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optical image in one window and then “unlink” the trace.  After this, one can select the 
autoradiograph, and the trace will transfer to the other image and be spatially 
representative of the sample in this image.  This is essential for determining the location 
of isotope in a tissue sample. 
 
 
 
Previous Applications 
 The MicroImager is a versatile imaging modality that has been used for a wide 
array of investigations.  Salin et al. (2000) has used the MicroImager to quantitatively 
analyze the expression of two mRNA species using double isotope in situ hybridization 
(8).  They labeled one oligonucleotide with 3H and another with 35S.  Their results 
indicate the MicroImager is capable of accurately discriminating between two different 
isotopes when used to investigate mRNA expression. 
 In a different study, Salin et al. (2002) applied the MicroImager to conduct a 
microarray investigation using 3H and 35S.  This study confirmed the high dynamic range 
and high resolution of the MicroImager are ideal for high density microarray analysis (9). 
Figure 7.  An optical image of rat subcutaneous tissue (left) and the 
[3H]dexamethasone autoradiogram (right) with a manual trace of the optical image 
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Our Applications 
The investigations conducted in this study evaluate transport characteristics of 
[3H]dexamethasone in rat subcutaneous tissue.  Several experiments were done to 
determine the elimination constant and diffusion coefficient of dexamethasone in tissue.  
Different methods were investigated that can be applied to different tissue types in the 
future.  The high speed and high resolution of the MicroImager were critical for the 
success of these investigations.  
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Chapter Two 
 
Distribution of [3H]Dexamethasone in Rat Subcutaneous Tissue After Delivery 
from Osmotic Pumps 
 
Introduction 
 
Several recent reports suggest that controlled local release of dexamethasone may 
be useful for preventing inflammation around an implantable glucose sensor (10-12). 
This decrease in inflammation is expected to increase glucose sensor function and 
lifetime. Local drug delivery may be achieved using biodegradable polymer implants 
(13), hydrogels (14) and osmotic pumps (15).  Local delivery of dexamethasone would 
permit high interstitial drug concentrations at the site of glucose sensor implantation 
without producing high systemic drug levels.  
 For successful local treatment, dexamethasone must be released and penetrate 
through the tissue surrounding the implanted glucose sensor. Additionally, the 
concentration of dexamethasone in the subcutaneous tissue surrounding the implanted 
glucose sensor must be high enough to prevent inflammation to an implant. In a previous 
study using dexamethasone to suppress inflammation to an implant, local distribution of 
the drug in subcutaneous tissue was not determined (10). Although dexamethasone is a 
commonly used anti-inflammatory agent, its local concentration, diffusion coefficient and 
rate of elimination have not been reported following subcutaneous release. The ability of 
dexamethasone to penetrate subcutaneous tissue can be measured and quantified by 
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comparison to mathematical models (13). This method allows a reliable estimate of the 
drug concentration in the tissue near the implanted glucose sensor.  
 Experiments were set up to examine the controlled delivery of dexamethasone in 
normal rat subcutaneous tissue in order to develop a fundamental understanding of how 
the drug is transported in the subcutaneous tissue.  Because the efficacy of controlled 
interstitial delivery depends on the distance the drug can penetrate into the tissue 
surrounding the implantable glucose sensor, [3H]dexamethasone was delivered from 
osmotic pumps that were implanted into the subcutaneous tissue of rats. Digital 
autoradiographic imaging was used to quantify the spatial distribution of radioactivity in 
the subcutaneous tissue at 6 hr, 24 hr and 60 hr after subcutaneous implantation. We 
investigated both the extent of penetration of dexamethasone and the effectiveness of 
simple transport models for quantification of penetration. From this quantification, the 
diffusion coefficient of dexamethasone in subcutaneous tissue and the rate of elimination 
of dexamethasone from the subcutaneous tissue were determined. This information is 
necessary for the future development of an optimal local delivery system of 
dexamethasone to reduce the inflammatory response and enhance in vivo sensor function 
and lifetime. 
 
Materials and Methods 
Materials 
 [3H]dexamethasone (392.46 MW), specifically [1,2,4,6,7-3H]dexamethasone, 
was obtained from Amersham Biosciences Corp. (Piscataway, NJ). The specific activity 
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was 88.0 Ci/mmol. Alzet osmotic pumps (1003D model) were obtained from Durect 
Corp. (Cupertino, CA). 
 
Preparation of Osmotic Pumps 
A solution of [3H]dexamethasone and sterile 0.9% (w/v) saline was loaded into 
the osmotic pumps (total volume 114 µl) using the protocol provided by the 
manufacturer. Each pump contained a total activity of 127 µCi. The pumps provided a 
controlled delivery at a rate of 1.0 µL/hr. To prevent the pump from causing a tissue 
reaction at the site of drug delivery, drug delivery was achieved via a 4 cm length of 
polyethylene tubing connected to the body of the pump. 
 
Subcutaneous Implantation 
Six male Sprague Dawley rats (Harlan, Indianapolis, IN, 375-399 g) were used 
for our studies. The rats were initially anesthetized by placing each rat in an induction 
chamber filled with a 5% mixture of isoflurane in oxygen. During surgery anesthetization 
of the rats was maintained using a 2.5% mixture of isoflurane in oxygen. Two pumps 
containing radiolabeled dexamethasone were implanted subcutaneously on either side of 
the shoulders of the rat. A 3-4 cm incision was made between the shoulder blades. A 
hemostat was inserted into the incision on the lateral aspect. By opening and closing the 
jaws of the hemostat a pocket in the subcutaneous tissue just large enough for the pump 
was created. A tunnel to insert the tubing was made using a blunt probe. Excess bleeding 
was removed with sterile cotton gauze. The osmotic pump was implanted tubing end 
first. The wound was closed with 4-6 surgical staples. 
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Two rats were euthanized at 6 hr, 24 hr, and 60 hr after implantation using CO2. 
The tissue around the tip of the catheter was removed, quickly frozen on dry ice and 
stored at -80°C to immobilize the tracers within the tissue sample. The frozen tissue 
samples were mounted on a cryostat chuck and cut in 10 µm sections. Sections taken at 
every 200 µm were used for autoradiographic imaging. In addition, sections 50 µm from 
those sections used for autoradiographic imaging were collected for hematoxylin-eosin 
(H&E) staining. 
All animal experiments were performed under the approval of the University of 
South Florida Animal Care and Use Program. 
 
Autoradiographic Imaging and Analysis 
Autoradiographic images of the tissue sections were obtained using a recently 
developed real-time digital radioactivity-detection system, the MicroImager (Biospace 
Mesures, Paris, France) (16, 17). With the MicroImager, acquisition of events can be 
visualized in real-time on a monitor screen. Each event is individually analyzed by the 
computer. An event is a radioactivity decay event (16). The acquisition of events need 
only proceed for as long as is necessary to obtain a good image. In our case, 
autoradiographic images with between 380,715 to 686,390 events were acquired over 24 
to 45 hours to obtain good images. An optical image of the same tissue sample using the 
MicroImager was also obtained.  
The spatial variation in drug concentration from the osmotic pumps was 
quantified in the following way. The areas of subcutaneous tissue were identified on the 
optical image and then superimposed onto the corresponding autoradiographic image. 
 16
The concentration profiles in the subcutaneous tissue surrounding the catheter tip were 
determined directly from the autoradiographic images using Beta Vision+ software 
(Biospace Mesures, Paris, France). A line profile tool (1 mm wide) was used from the 
center of the catheter tip to the periphery of the subcutaneous tissue to obtain a number of 
events versus distance profile. The background number of events was subtracted from the 
number of events acquired. A number of events versus distance profiles were performed 
at 15° increments around the catheter tip on each section selected for analysis. The 
number of events at the catheter tip opening was calibrated to the known concentration of 
the agent in the pump to obtain concentration versus distance profiles at 6 hr, 24 hr and 
60 hr after implantation. 
 
Mathematical Model 
The concentration profiles of [3H]dexamethasone obtained using the MicroImager 
were compared to a mathematical model of drug diffusion and elimination. The model 
assumed: 1) constant drug concentration at the catheter tip/tissue interface; 2) first-order 
elimination of drug; 3) isotropic diffusional transport of drug through the subcutaneous 
tissue; 4) negligible fluid convection; and 5) spherical symmetry. The governing equation 
for the diffusion and elimination of a drug in subcutaneous tissue is: 
kC
r
C
rr
CD
t
C −⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂+∂
∂=∂
∂ 2
2
2
       (eq 1) 
where C is the concentration of the drug in the subcutaneous tissue, D is the diffusion 
coefficient of the drug in subcutaneous tissue, r is the radial distance from the center of 
the catheter tip, k is the first-order elimination constant for the drug from the 
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subcutaneous tissue and t is the time after implantation. The boundary and initial 
conditions are: 
C = 0    at t = 0;  r ≥ a  
 C = C0   at t > 0; r = a    (eq 2) 
 C = 0    at t > 0;  r → ∞ 
where a is the radius of the catheter and C0 is the concentration at the catheter tip. The 
solution of eq 1 using the boundary and initial conditions of eq 2 is (22):  
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 (eq 3) 
Assuming steady state, and applying the two boundary conditions from eq 2, eq 1 
can be solved using a series solution. Alternatively, the steady state solution can also be 
found from eq 3 by applying the limit t→∞: 
⎥⎦
⎤⎢⎣
⎡ −−=
D
kar
r
a
C
C )(exp
0
       (eq 4) 
The Brownian diffusion coefficient for dexamethasone in water was estimated 
from the Stokes-Einstein equation: 
As Nr
TD πµ
κ
6
=         (eq 5) 
where rs = 0.657 M
1/3 [x10-10 m] is the equivalent spherical solute radius, M is the 
molecular weight of dexamethasone (392.46 MW), κ is the ideal gas constant 8.314  
JK-1mol-1, T is temperature, µ dynamic viscosity and NA is Avogadro’s number. The 
calculated diffusion constant of dexamethasone in water at 37°C is D = 6.82x10-10 m2/s. 
The Stokes-Einstein equation underpredicts the actual diffusion coefficient for small 
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solutes of molecular weight less than several hundred, and overpredicts it for large 
solutes of molecular weight greater than several thousand (19).  
Measured concentration profiles for [3H]dexamethasone at t = 6 hrs, t = 24 hrs 
and t = 60 hrs were compared to the transient equation (eq 3). Typical concentration 
profiles predicted by eq 3 for two values of φ for various times are shown in figures 8a 
and 8b. The dimensionless parameter φ, where φ= Dka / , is analogous to the Thiele  
 
 
 
 
Figure 8.  Concentration versus distance profiles obtained by solving the transient 
diffusion and elimination equation (eq 3) for various times until steady state is 
reached are shown. Panels a and b demonstrate the dependence of the penetration 
depth with the modulus φ = k/Da . Panel a (φ = 0.2) has a larger penetration 
depth than panel b (φ = 1) 
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modulus obtained in analysis of heterogeneous catalysis (13) and is a predictor of the 
extent of drug penetration from the catheter tip. 
The radius of the catheter was approximated at 0.6 mm. Values for D and k were 
found in the following manner. First, initial estimates for D and k were found. For the 
initial estimate of D, the diffusion constant for dexamethasone in water was used, D = 
6.82x10-10 m2/s. This D was used in the steady-state solution of the diffusion equation (eq 
4) to find an initial estimate for k. k was found by using the Marquardt-Levenberg 
technique (20) with two independent variables, k and C0, to minimize the residual of the 
sum-squared-error between the predicted and experimental concentrations. Second, these 
initial estimates for the k and D values were then used as the starting points for the 
Marquardt-Levenberg algorithm using the transient equation (eq 3) with the k, D, and C0 
being the three independent variables over which the residual of the sum-squared-error 
between the predicted and experimental concentrations was to be minimized.  The initial 
value for C0 was always the maximum concentration in the measured data set.  The 
Marquardt-Levenberg algorithm efficiently searched over the k, D, and C0 space to find 
the point which best fits the data (21).  This technique was repeated to find k and D for 6 
hr, 24 hr, and 60 hr.  For each of these times, the calculations were repeated for the 
autoradiographic scans at various angles. The Marquardt-Levenberg algorithm was 
written in MATLAB. 
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Results 
Radiolabeled dexamethasone spread through the subcutaneous tissue after 
implantation of the osmotic pump (fig. 9). The local concentration of drug within the 
tissue was quantified from the autoradiographic images using the Beta Vision+ software. 
The Beta Vision+ software was used to construct the number of events as a function of 
distance profiles. An event is a radioactivity decay event (16). The number of events was 
greatest at the tip of the catheter. A high number of events on the autoradiographic image 
represents a high drug concentration. The number of events at the tip of the catheter can 
be calibrated to the known concentration in the pump. Hence, the local concentration of 
the drug in the subcutaneous tissue surrounding the catheter can be estimated by 
comparing the local number of 
events to the number of events at 
the catheter tip. In general, at 
distances more than a few 
millimeters from the catheter tip, 
the radioactivity was not 
significantly different from 
background. Figure 9 is 
representative of the 
autoradiographic images obtained 
using the MicroImager after 
implantation of the osmotic pumps 
for 6 hr, 24 hr, or 60 hr.  
Figure 9.  Autoradiographic image from rat 
subcutaneous tissue obtained using the MicroImager 
after implantation of an osmotic pump containing 
[3H]dexamethasone for 6 hrs. The location and 
direction of the catheter tip is shown by the arrow. 
Each red dot represents a radioactivity decay event. 
Lighter shades indicate higher activity. The bar 
represents a distance of 1 mm. 
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Concentration profiles obtained from the autoradiographic images of the 
subcutaneous tissue surrounding the catheter tip were examined and compared to the 
mathematical model of diffusion and first-order elimination to find the best estimates for 
D and k. 
The best estimates obtained for D and k are given in Table 1. A single-factor 
analysis of variance (ANOVA) indicated that there was no significant difference between 
the 6 hr and 24 hr data for k (p > 0.05) or for D (p > 0.05). There was not enough data at 
60 hr for comparison. The average, based on the 6 hr, 24 hr and 60 hr data, for the 
diffusion coefficient is D = 4.11 ± 1.77 x10-10 m2/s and for the elimination constant is k = 
3.65 ± 2.24 x10-5 s-1. 
Table 1. Estimated D and k 
The diffusion coefficient and elimination constant was determined by fitting a 
model of diffusion and elimination to the concentration profiles measured near the tip of 
a catheter attached to an osmotic pump. 
Time after 
implantation 
n k [1/s] x 10-5 D [m2/s] x 10-10 
6 hr 5 4.80 ± 2.56 3.63 ± 1.06 
24 hr 6 2.52 ± 1.65 4.92 ± 1.97 
60 hra 1 4.70 1.73 
a Only one scan was suitable for analysis in this case, as the subcutaneous tissue 
was very thin, allowing measurement without boundary effects only in one case. 
 
To quantify differences in drug penetration with time after release from the 
osmotic pump, the best fit concentration profiles were used to find the distance where the 
local concentration drops to 10% of its maximum value (figs. 10a, b, c). For the 6 hr case, 
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the majority of the drug was confined to a region within 2.22 ± 0.42 mm from the tip of 
the catheter (table 2). For the 24 and 60 hr cases, the majority of the drug was confined to 
a region within 2.70 ± 0.38 mm and 1.80 mm from the tip of the catheter, respectively. 
The penetration distance of [3H]dexamethasone increased from 6 hr to 24 hr, but 
decreased from 24 hr to 60 hr. 
  
 
Figure 10.  Typical concentration profiles in the vicinity of the catheter tip at (a) 
6 hr, (b) 24 hr and (c) 60 hr after implantation. Data from only one angle per 
time period is shown. Combining data from all. 9other scans would make the 
figure unreadable. The solid lines show the transient diffusion and elimination 
model (which reduces to the steady state model as t→∞) in which k, D and C0 
was varied to minimize the residual of the sum-squared-error between the 
predicted and experimental values. The ordinate represents the location of 
catheter tip/tissue interface 
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Table 2. Penetration distance of radioactivity from the tip of the catheter 
The penetration distance is the distance where the local concentration drops to 
10% of the concentration at the catheter tip. This radial distance was found using the best 
fit curve through the data and corresponds to the location where C/C0 = 0.1. The 
dimensionless parameter, φ= Dka / , determines the extent of drug penetration and was 
found using the corresponding k and D values in Table 1. 
Time after 
implantation 
Penetration 
Distance [mm] φ = Dka /  
6 hr 2.22±0.42 0.22 
24 hr 2.70±0.38 0.14 
60 hr 1.80a 0.31 
a See note on table 1. 
 
Discussion 
Radiolabeled dexamethasone was introduced into the subcutaneous tissue by 
implantation of osmotic pumps. There was constant delivery of the agent from the pump 
via an attached catheter. High concentrations of the agent were located near the tip of the 
catheter. The local distribution of the agent in the subcutaneous tissue surrounding the 
catheter tip was measured and analyzed. The distribution of the agent within the 
subcutaneous tissue near the catheter tip was consistent with the mathematical model of 
diffusion and first-order elimination (figs. 10a, b, c). The mathematical model was 
compared to the experimental data in order to obtain values for the diffusion coefficient 
D, and the elimination constant k at 6 hr, 24 hr and 60 hr after implantation. The 
experiment was terminated at the end of 60 hr as the concentration profile reached steady 
state at 60 hr (fig. 8a) (further discussion below). 
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The diffusion coefficient, D, of dexamethasone in subcutaneous tissue at 6 hr and 
24 hr after implantation was 3.63 ± 1.06 x10-10 m2/s and 4.92 ± 1.97 x10-10 m2/s, 
respectively. The 60 hr data suggests a D of 1.73 x10-10 m2/s. There was no significant 
difference between the 6 hr and 24 hr data for D (p > 0.05). A comparison with the 60 hr 
data was not made as the sample size was too small. Even though the concentration 
profile at 6 hr has not yet reached steady state (fig. 8a), the value found for D should not 
be different from that found for the 24 hr case which is very close to steady state. (Note 
that at 6 hr, φ = 0.22 (table 2) and fig. 8a shows concentration profiles for φ = 0.2 for 
various times.) The concentration profile at 60 hr has reached steady state (fig. 8a). D 
should have similar values at 6 hr, 24 hr and 60 hr because the best estimate for D and k 
for all cases was achieved using the transient diffusion and elimination equation (eq 3). 
Since the transient equation takes time into account, be it for a short time period or for a 
long time period, the D and k values for the same agent in the same tissue should be the 
same. D and k are assumed to be constants. As time becomes large, the transient equation 
(eq 3) reduces to the steady equation (eq 4). Hence, the average diffusion coefficient D = 
4.11 ± 1.77 x10-10 m2/s based on the 6 hr, 24 hr and 60 hr data, results in a reasonable 
value for dexamethasone in subcutaneous tissue. The diffusion coefficient of 
dexamethasone in subcutaneous tissue is slightly less than in water but slightly greater 
than in brain tissue (table 3). Our diffusion coefficient for dexamethasone in rat 
subcutaneous tissue is slightly greater than the diffusion coefficient of sodium fluorescein 
(molecular weight 376) in rat subcutaneous tissue D = 2.35 ± 0.24 x 10-10 m2/s (24). 
Sodium fluorescein has a similar molecular weight as dexamethasone (molecular weight 
392). 
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Table 3. Diffusion coefficients for dexamethasone in various media 
 
The diffusion coefficient of dexamethasone in subcutaneous tissue was compared 
to the diffusion coefficient for dexamethasone in other media from the literature. 
Medium D [m2/s] Reference 
water 6.82 x 10-10 Stokes-Einstein equation 
subcutaneous tissue 4.11±1.77 x 10-10 This study 
brain tissue 2.0 x 10-10 Saltzman and Radomsky, 1991 (22) 
cellulose acetate membrane 3.15 x 10-11a Barry and Brace, 1977 (23) 
a Interpolated for 37°C 
The elimination constant, k, at 6 hr and 24 hr was 4.80 ± 2.56 x10-5 s-1 and 2.52 ± 
1.65 x10-5 s-1, respectively. The 60 hr data suggests a k of 4.70 x10-5 s-1. There was no 
significant difference between the 6 hr and 24 hr data for k (p > 0.05). A comparison with 
the 60 hr data was not made as the sample size was too small. The average, based on the 
6 hr, 24 hr and 60 hr data, for the elimination constant is k = 3.65 ± 2.24 x10-5 s-1. This 
value is quite reasonable despite the fact that the 6 hr case has not yet reached steady 
state for the reasons given in the paragraph above. Table 4 shows values for k of other 
agents in subcutaneous tissue. Our elimination constant for dexamethasone in rat 
subcutaneous tissue is slightly greater than that of dexamethasone in rat brain 
k = 1.19 x 10-5 s-1 (26). 
Although only two rats were used for each time point, we did not observe any 
variation between the two rats as they were the same age, sex, size, and strain and were 
all from the same vendor. A detailed study would be useful to demonstrate that the age, 
sex, size, strain and vendor have no significant effect on the values of D and k. However, 
this extensive work is beyond the scope of this paper. 
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Table 4. Elimination constants of various agents in subcutaneous tissue 
The elimination constant of dexamethasone in subcutaneous tissue was compared 
to the elimination constant of other agents in subcutaneous tissue from the literature. 
Agent k [1/s] Reference 
RSAa 6.42±1.19 x 10-5 Kim and Burgess (2002) (16) 
Dexamethasone 3.65±2.24 x10-5 This study 
VEGFb 3.50±1.03 x 10-5 Kim and Burgess (2002) (16) 
a rat serum albumin 
b vascular endothelial growth factor 
 
Dexamethasone penetrated an average distance of 2.22 ± 0.42 mm at 6 hr, 2.70 ± 
0.38 mm at 24 hr and 1.80 mm at 60 hr into the subcutaneous tissue near the implant 
(table 2). The difference between the penetration distances at 6 hr and 24 hr is most likely 
due to the fact that at 6 hr steady state has not yet been reached and hence, the furthest 
extent of drug penetration has not yet been reached (fig. 8a). The reduction in penetration 
distance at 60 hr compared to that at 24 hr may be explained from an analysis of the H&E 
stained slides. Histopathological evaluation of the slides revealed that there were more 
inflammatory cells at 60 hr than for 24 hr after implantation. It should be noted that the 
actual amount of [3H]dexamethsone used for this study was very small. This amount of 
[3H]dexamethasone after 60 hr of delivery resulted in slightly less than the maximum 
amount of radioactivity allowed in an animal for normal disposal. This small amount of 
dexamethasone would not have had a significant effect on the number of inflammatory 
cells. The number of inflammatory cells may have affected the transport characteristics. 
Kim et al. (25) also suggested that the body’s inflammatory response to local delivery 
devices located at a subcutaneous site may complicate drug release. 
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The average φ, based on the average values for D and k, is φ = 0.18.  Since D and 
k values for the same agent in the same tissue are assumed to be constants, then 
φ= Dka /  must also be a constant. Although the modulus φ determines the extent of 
drug penetration, the penetration distance for a given φ may be different at different times 
(figs. 8a, b). The maximum extent of drug penetration is not reached until steady state is 
reached. At times prior to steady state, the penetration distance is less then maximum. In 
general, the penetration distance increases as φ decreases (figs. 8a, b) because the rate of 
diffusion is greater than the rate of elimination. The modulus φ is useful in predicting the 
extent of drug penetration between different drugs at steady state. 
The model also assumed isotropic 
diffusional transport of drug through the 
subcutaneous tissue. Figure 11 shows a typical 
H&E stained tissue section from our study. 
The subcutaneous tissue was homogeneous. 
Hence, the assumption that the tissue would 
be isotropic for diffusional transport seems 
reasonable. 
Our model of drug distribution within 
the subcutaneous tissue assumes that drug 
transport occurs predominately by diffusion.  
The Peclet number (Pe = va/D), where v is the velocity of the dexamethasone solution in 
the tissue and a is the radius of the catheter, was 0.18. Hence, this assumption is 
acceptable. 
Figure 11.  A typical H&E stained 
tissue section from our study. The bar 
represents a distance of 100 µm   
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The model assumed spherical symmetry, although the delivery of drug was from a 
pipe. As the model was consistent with the data (figs. 10a, b, c), this assumption appears 
to be acceptable. 
From other experiments in our laboratory, we have determined the minimum 
dosage of dexamethasone that would prevent inflammation to a glucose sensor implanted 
subcutaneously. This dosage was found to be 0.12 mg per day (unpublished data). 
Knowledge of this minimum value along with the values of the diffusion coefficient and 
elimination constant found in this study, one can design an effective and efficient local 
drug delivery system around any implantable glucose sensor or implant whose function is 
affected by inflammation.  
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Chapter Three  
 
Diffusion of [3H]Dexamethasone in Rat Subcutaneous Slices after Injection 
Measured by Digital Autoradiography 
 
Introduction 
Many transport experiments are based on the injection of a finite volume of 
substance into the tissue of interest which then diffuses away. Some examples of 
injection based diffusion experiments are: the determination of the diffusion coefficient 
of small molecules in the brain (27); the determination of the diffusion coefficient of 
growth factors in the brain (28); and the determination of the diffusion coefficient of 
drugs in tumors (29, 30). Knowledge of the diffusion of a substance of interest in the 
tissue of interest is important for treatment efficacy. In this paper, we will derive a 
method in which the diffusion coefficient of an injected substance in tissue can be 
determined in a relatively simple manner. We will illustrate this technique by finding the 
diffusion coefficient of [3H]dexamethasone in rat subcutaneous slices after an injection. 
 
Materials and Methods 
Materials 
[3H]dexamethasone (392.46 MW), specifically [1,2,4,6,7-3H]dexamethasone, was 
obtained from Amersham Biosciences Corp. (Piscataway, NJ). The specific activity was 
88.0 Ci/mmol.  
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Subcutaneous Injection 
Three male Sprague Dawley rats (Harlan, Indianapolis, IN, 375-399 g) were used 
for our studies. The rats were euthanized using CO2 prior to the experiment. 
The 20 minute experiment: Three 40 µl solutions of [3H]dexamethasone in sterile 
0.9% (w/v) saline were used. Injections were made into subcutaneous tissue. Each 
solution contained a total activity of 0.65 µCi. The tissue around the injection site was 
removed and frozen on dry ice. The average time from injection to when the tissue froze, 
as measured using a surface thermometer (Mannix Testing & Measurement, Lynbrook, 
NY), was approximately 20 minutes after injection.  
The 157 second experiment: Three subcutaneous sections were harvested. Each 
section was injected with 40 µl solutions of [3H]dexamethasone in sterile 0.9% (w/v) 
saline and then frozen on dry ice. The average time from injection to when the tissue 
froze was approximately 157 seconds after injection.  
All tissue samples were then stored at -80°C to immobilize the tracers within the 
tissue sample. The frozen tissue samples were mounted on a cryostat chuck and cut in 10 
µm sections. Sections taken at every 200 µm were used for autoradiographic imaging.  
All animal experiments were performed under the approval of the University of 
South Florida Animal Care and Use Program. 
 
Autoradiographic Imaging and Analysis 
Autoradiographic images of the tissue sections were obtained using a real-time 
digital radioactivity-detection system, the MicroImager (Biospace Mesures, Paris, 
France) (16, 17). With the MicroImager, acquisition of events can be visualized in real-
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time on a monitor screen. The acquisition of events needs only to proceed for as long as 
is necessary to obtain a good image. In our case, autoradiographic images with between 
1,593,815 to 1,918,869 events were acquired over 71 h 32 min to 72 hr 43 min to obtain 
good images.  
The spatial variation in drug concentration from the injection was quantified as 
follows. A grid was placed over the autoradiographic image using the Beta Vision + 
software (Biospace Mesures, Paris, France) to determine the number of events in each 0.3 
x 0.33 mm grid area. The grid area that contained the highest number of events (or 
greatest radioactivity) was taken to be the center of the injection. The concentration 
profiles versus distance in the subcutaneous tissue surrounding the center of injection 
were determined directly from the autoradiographic images using the Beta Vision+ 
software (Biospace Mesures, Paris, France). A line profile tool (1 mm wide) was used 
from the center of the injection to the periphery of the subcutaneous tissue to obtain a 
number of events versus distance profile. The background number of events was 
subtracted from the number of events acquired. The number of events can be calibrated to 
concentration. 
Mathematical Model 
The concentration profiles of [3H]dexamethasone obtained using the MicroImager 
were compared to a mathematical model of drug diffusion. The model assumed 1) that 
the diffusing substance is deposited within a sphere of radius a at t = 0; 2) isotropic 
diffusional transport of drug through the subcutaneous tissue; 3) negligible fluid 
convection; and 4) negligible elimination. Assuming that the elimination is negligible is 
justified as tissue samples were obtained from a sacrificed rat. That is, the absence of 
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blood flow eliminates most clearance mechanisms normally present in vivo (28). Hence, 
the governing equation for diffusion of a drug in the subcutaneous tissue is: 
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where C is the concentration of the drug in subcutaneous tissue, D is the diffusion 
coefficient of the drug in subcutaneous tissue, r is the radial distance from the center of 
the injection and t is the average time from injection to when the tissue froze. The initial 
concentration is Co in the sphere, 0 ≤ r < a and zero for r > a. The boundary conditions is 
C( ∞, t) = 0. The analytic solution for eq 6 using the above initial and boundary 
conditions is (18, 31): 
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where a is the radius of the sphere. 
If r >> a, then expression (eq 7) becomes (18): 
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where m = VCo = 4/3πa3Co, and V is the injected volume. 
If the radius of the sphere tends to zero, a→0, with m remaining constant (18): 
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 Equation 9 is the same solution as for the instantaneous point source in 3D (32). 
However, Nicholson (33) suggests that at measurement locations sufficiently far from the 
source, eq 9 (or eq 10) will provide a useful approximation. Moreover, Thorne et al. (28) 
suggest that when the injection time is very brief compared to the time of the subsequent 
diffusion measurements, the concentration can be described by eq 9 (or eq 10). 
Typical concentration profiles for 
[3H]dexamethasone predicted by eq 10 at t 
= 2.5 min, t = 5 min, t = 10 min, and t = 20 
min are shown in Figure 12.  
The radius of the injected spherical 
volume was 2.1 mm. For eq 5 to be a 
useful approximation, data away from the 
source was used (33). For the 20 min experiment, 
a portion of the concentration profile from the 
tail-end was used in the mathematical model. 
This portion ranged from the tail-end to a 
position 3 mm towards the source from the first zero event value. For the 157 s 
experiment, first zero event value could not be used as reference point. Instead, a location 
on the profile where the profile “bends” from a steep curve to a plateau region was used 
as a reference.  This “bend” was defined to occur at a position where the number of 
events was 100. Therefore, the portion of the concentration profile used in the 
mathematical model was from the tail-end to a distance 0.7 mm towards the source after 
the “bend”. The reason that the first zero event value could not be used as a reference 
Figure 12.  Concentration profiles for 
diffusion when a concentrated bolus 
of solute is deposited within a small 
region. The curves shown are a 
realization of eq 5 with  
D = 4.11 x 10-10 m2/s, a = 0.21 cm, 
and t = 2.5 min, 5 min, 10 min, and 
20 min
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point will be discussed further in the discussion section below. The value for D was 
found in an iterative manner. First, an initial estimate for D was needed. The diffusion 
constant for dexamethasone in water was used, D = 6.82x10-10 m2/s (34). This initial 
estimate for D was then used as the starting points for the Marquardt-Levenberg 
algorithm (20) with the D, and C0 being the two independent variables over which the 
residual of the sum-squared-error between the predicted and experimental concentrations 
was to be minimized.  The initial value for C0 was always the maximum concentration in 
the measured data set.  The Marquardt-Levenberg algorithm efficiently searched over the 
D, and C0 space to find the point which best fits the data (21).  This technique was 
repeated to find D for 157 s and 20 min.  For each of these times, the calculations were 
repeated for the autoradiographic scans at various angles. The Marquardt-Levenberg 
algorithm was written in MATLAB. 
 
Results 
Radiolabeled dexamethasone spread through the subcutaneous tissue after 
injection. Figure 13 is representative of the autoradiographic images obtained using the 
MicroImager after injection of a radiolabeled drug. The local concentration of drug 
within the tissue was quantified from the autoradiographic images using the Beta Vision+ 
software. The Beta Vision+ software was used to construct the number of events as a 
function of distance profiles. Figure 14 is representative of the number of events versus 
distance profiles obtained from the autoradiographic images. An event is a radioactivity 
decay event (16). The number of events was greatest at the center of the injection. A high 
number of events on the autoradiographic image represent a high drug concentration. The 
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number of events can be calibrated to concentration to obtain concentration versus 
distance profiles. 
 
 
 
 
 
 
 
 
 
 
 
 
a b
Figure 13. Image a shows a typical autoradiographic image obtained using the 
MicroImager 157 s after injection of [3H]dexamethasone. Image b shows an 
autoradiographic image 20 min after injection of [3H]dexamethasone. Red indicates 
higher activity than green. The bar represents a distance of 2 mm 
Figure 14.   Typical number of events versus distance profiles obtained using the 
MicroImager at (a) 157 s and (b) 20 min after implantation. Data from only one 
scan is shown. Combining data from all other scans would make the figure 
unreadable. The ordinate represents the location of the center of injection 
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For the 20 min case, the concentration profile from the tail-end to 3 mm towards 
the source was compared to the mathematical model of diffusion to find the best estimate 
for D. For the 157 s case, the concentration profile from 0.7 mm towards the source from 
the “bend” to the tail-end was compared to the mathematical model of diffusion to find 
the best estimate for D. The best estimates obtained for D are given in Table 5.  
Table 5. Estimated diffusion coefficient 
The diffusion coefficient was determined by fitting a model of diffusion to the 
concentration profiles from the tail-end of the profiles. 
Time after Injection n D [m2/s] x 10-10 
157 s 18 2.68 ± 1.08 
20 min 22 4.01 ± 2.01 
 
Discussion 
When a substance is injected into tissue in a period that is effectively 
instantaneous it may exhibit two distinct behaviors: 1) form a fluid-filled cavity; or 2) 
infiltrate the extracellular space of the tissue (33).  The subsequent diffusion from each 
case can be described by its own set of expressions (33). In this study, we have assumed 
that the substance does not form a cavity but infiltrates the extracellular space and then 
diffuses away and hence, have used the appropriate solutions and their approximations 
for this case.  
The approximations to the case where substance infiltrates the extracellular space 
lead to eq 10. The two criteria for eq 10 to provide a useful approximation are: 1) that the 
measurement locations be sufficiently far from the source (33); and 2) that the injection 
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time is very brief compared to the time of the subsequent diffusion measurements (28). 
To comply with criteria 1, the data near the tail-end of the concentration profiles was 
used as described below. The measurement distance was kept as small as possible while 
large enough to provide meaningful data. To investigate criteria 2, two diffusion times 
were chosen t = 157 s and t = 20 min. 
For our study, radiolabeled dexamethasone was introduced into the subcutaneous 
tissue by injection. Highest concentrations of the agent were assumed to be the location 
of the center of the injection. This assumption is supported by our theoretical curves 
(Figure 12). The local distribution of the agent in the subcutaneous tissue surrounding the 
center of injection was measured (Figure 14).  
The local distribution of the agent at the tail end of the distribution was compared 
to the mathematical model of diffusion. For the 20 min case, the mathematical model was 
compared to the local distribution from the tail-end to a distance 3 mm towards the center 
of the injection from the first zero event value.  For the 157s case, the mathematical 
model was compared to the local distribution from the tail-end to a distance 0.7 mm 
towards the center of the injection from a “bend”.  The concentration profile “bends” 
from a steep curve to a plateau region.  The “bend” was defined to be the position where 
the number of events had a value of 100 (see Figure 14a). The plateau region was defined 
as having a relatively flat profile where the events values where between 0 and 100.  The 
position of the first zero event value could not be used as a reference as the plateau region 
varied greatly in length. Hence, it would not be possible to set a specified measurement 
distance from the first zero event value. A plateau region was not seen with the 20 min 
data. 
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The distribution of the agent within the subcutaneous tissue at the tail-end of the 
concentration profile was consistent with the mathematical model of diffusion (Figure 
15). The mathematical model was compared to the experimental data in order to obtain 
values for the diffusion coefficient D at 157s and 20 min after injection.  
 
 
 
 
 
 
 
 
The diffusion coefficient, D, of dexamethasone in subcutaneous tissue slices at 
157 s and 20 min after injection was 2.69 ± 1.08 x 10-10 m2/s and 4.01 ± 2.01 x 10-10 m2/s, 
respectively.  
As mentioned above, there were two criteria for eq 10 to provide a useful 
approximation. To comply with criteria 1, the data near the tail-end of the concentration 
profiles was used. However for a few of the concentration profiles for the t = 157 s case, 
using data 0.7 mm towards the source from the “bend” meant using all the data as the 
profile was very steep (Figure 15a). Hence, criteria 1 for t = 157 s could not be complied 
with. For the 20 min case, there was an offset ranging from 0.77 mm to 2.25 mm from the 
Figure 15. Concentration profiles at the tail-end at (a) 157 s and (b) 20 min 
after injection. Data from only one angle per time period is shown. 
Combining data from all other scans would make the figure unreadable. 
The solid lines show the diffusion model in which D and C0 was varied to 
minimize the residual of the sum-squared-error between the predicted and 
experimental values 
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center of the injection. Although this offset is not large, it may be sufficient enough to 
comply with criteria 1. In addition, data in Nicholson (33) show that the accuracy of eq 
10, at measurement distances close to the source, increases with time. 
Criteria 2 required that the injection time be very brief compared to the time of 
the subsequent diffusion measurements. Although the injection time was not measured, 
the injection of 40 µl of substance was very brief.  The two diffusion times were t = 157 s 
and t = 20 min. The t = 157 s concentration profile had a plateau region that was not seen 
in the t = 20 min concentration profile. It could be that at t = 157 s, the injected substance 
formed both a fluid-filled cavity and infiltrated the extracellular space to some degree 
producing the plateau region. If this is the case, then eq 10 would not be the appropriate 
expression. This is a phenomenon that needs to be investigated further and is beyond the 
scope of this study. The concentration profile at t = 20 min is similar in shape to the 
theoretical curves realized by using eq 10 (Figure 12), whereas the concentration profile 
for the t = 157 s is not similar due to the plateau region. Hence, we will assume that for t 
= 157 s the diffusion time was not long enough and that eq 5 does not provide a useful 
approximation in this case.  A diffusion time of t = 20 min probably provides an adequate 
diffusion time and hence, eq 10 does provide a useful approximation.  
Therefore, the best estimate for the diffusion coefficient of dexamethasone in 
subcutaneous tissue slices based on the t = 20 min data is D = 4.01 ± 2.01 x10-10 m2/s. 
We previously found a diffusion coefficient, D = 4.11 ± 1.77 x10-10 m2/s, for 
dexamethasone in subcutaneous tissue using different experimental and mathematical 
techniques (34).  The diffusion coefficient was determined by fitting a model of diffusion 
and elimination to the concentration profiles measured near the tip of a catheter attached 
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to an osmotic pump containing [3H]dexamethasone that was implanted in rats for 6 h, 24 
h and 60 h (34). These values for D are very similar suggesting that eq 10 provide an 
adequate approximation as long as the two criteria are met.  
Our mathematical model assumed that the diffusing substance was deposited 
within a sphere at t = 0. Figure 13a shows the shape of the injection at 157 s is relatively 
spherical. Hence, the assumption that the injected volume at t = 0 was spherical is 
acceptable.  
The mathematical model also assumed isotropic diffusional transport of drug 
through the subcutaneous tissue. Figure 13b shows the diffusion of the drug at t = 20 min 
and diffusion is relatively spherical away from the site of injection. Hence, our 
assumption of isotropic diffusional transport is reasonable. 
The elimination constant was assumed to be negligible as the injections were 
made in either harvested subcutaneous tissue or in a euthenized rat so that the normal 
clearance processes that depend on circulation of blood was eliminated (33). In vivo 
concentration distributions are more complex and neither diffusion nor elimination can be 
neglected. 
In conclusion, eq 10 provides an adequate approximation for measurement 
locations sufficiently far from the source and for diffusion times much longer than the 
injection time (28, 33). The main advantages of this injection technique to determine an 
approximation for the diffusion coefficient are that it is relatively simple technique, and 
can be applied to any radiolabeled substance of interest injected into any tissue of 
interest. 
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Chapter Four 
 
Summary and Future Work 
MicroImager 
  The MicroImager is a highly sensitive autoradiographic imaging modality 
open to various applications.  While the machine is expensive, the cost of obtaining each 
image is low and can be done quickly.  A tissue sample is placed on a slide and covered 
with a sheet of scintillating paper.  This is placed in the machine then autoradiography is 
performed.  The PC associated system stores the data digitally and is easily accessible for 
storage and processing.  This autoradiographic machine can also be used to evaluate the 
distribution of two different isotopes in a sample. 
 
Osmotic Pump 
 Tritium labeled dexamethasone was placed within osmotic pumps and implanted 
into several Sprague Dawley rats.  The implants were removed at several time intervals 
and surrounding tissue was obtained for evaluation.  Samples were imaged using the 
MicroImager and spatial distribution of the radiolabeled dexamethasone was obtained.  
Mathematical models were created and best fit to experimental results.  Using curve 
fitting, the diffusion coefficient and elimination constant of dexamethasone in 
subcutaneous tissue were obtained.   
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Injection Study 
 Tritium labeled dexamethasone was injected into rat subcutaneous tissue to 
determine its behavior.  After injection, the tissue was explanted and frozen very quickly.  
Two time points were tested as 2.5 min and 20 min.  Mathematical models were obtained 
and matched to the experimental distribution curves.  This study developed a new method 
to obtain the diffusion coefficient of dexamethasone in any rat subcutaneous tissue.  This 
method can also be applied to different drugs in different tissues.   
 
Possible Future Work 
The MicroImager is a versatile imaging modality with many possible applications.  
Building on this research, experiments can go forward to evaluate receptor-ligand 
interactions in the brain.  For example, [3H]nicotine can be used to label nicotine 
receptors in the brains of adult and adolescent rats to investigate adolescent vulnerability 
to nicotine addiction ( Moussy and Wecker, personal communication).  In addition, future 
work can also investigate the dual imaging capability of this machine.  Some work has 
already been done investigating this capability.  [3H]glucose and 14[C]dextran were used 
to investigate the permeability of blood vessels (not published).  While minimal results 
were obtained, this study will be useful in preparing future investigations using dual 
labeling.  Future work may include using radiolabeled drugs for the treatment of brain 
tumors while simultaneously monitoring the metabolism at this site using radiolabeled 
glucose. 
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